A New Method for Time Normalization Based on the Continuous Phase: Application to Neck Kinematics

There is growing interest in analyzing human movement data for clinical, sport, and ergonomic applications. Functional Data Analysis (FDA) has emerged as an advanced statistical method for overcoming the shortcomings of traditional analytic methods, because the information about continuous signals can be assessed over time. This paper takes the current literature a step further by presenting a new time scale normalization method, based on the Hilbert transform, for the analysis of functional data and the assessment of the effect on the variability of human movement waveforms. Furthermore, a quantitative comparison of well-known methods for normalizing datasets of temporal biomechanical waveforms using functional data is carried out, including the linear normalization method and nonlinear registration methods of functional data. This is done using an exhaustive database of human neck flexion-extension movements, which encompasses 423 complete cycles of 31 healthy subjects measured in two trials of the experiment on different days. The results show the advantages of the novel method compared to existing techniques in terms of computational cost and the effectiveness of time-scale normalization on the phase differences of curves and on the amplitude of means, which are assessed by Root Mean Square (RMS) values of functional means of angles, angular velocities, and angular accelerations. Additionally, the confidence intervals are obtained through a bootstrapping process.

Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study

Modeling of retrospectively collected multi-center data of a rare disease in pediatrics is challenging because laboratory data can stem from several decades measured with different assays. Here we present a retrospective pharmacometrics (PMX) based data analysis of the rare disease congenital hypothyroidism (CH) in newborns and infants. Our overall aim is to develop a model that can be applied to optimize dosing in this pediatric patient population since suboptimal treatment of CH during the first 2 years of life is associated with a reduced intelligence quotient between 10 and 14 years. The first goal is to describe a retrospectively collected dataset consisting of 61 newborns and infants with CH up to 2 years of age. Overall, 505 measurements of free thyroxine (FT4) and 510 measurements of thyrotropin or thyroid-stimulating hormone were available from patients receiving substitution treatment with levothyroxine (LT4). The second goal is to introduce a scale/location-scale normalization method to merge available FT4 measurements since 34 different postnatal age- and assay-specific laboratory reference ranges were applied. This method takes into account the change of the distribution of FT4 values over time, i.e. a transformation from right-skewed towards normality during LT4 treatment. The third goal is to develop a practical and useful PMX model for LT4 treatment to characterize FT4 measurements, which is applicable within a clinical setting. In summary, a time-dependent normalization method and a practical PMX model are presented. Since there is no on-going or planned development of new pharmacological approaches for CH, PMX based modeling and simulation can be leveraged to personalize dosing with the goal to enhance longer-term neurological outcome in children with the rare disease CH.

IDENTIFICATION AND ESTIMATION IN A CORRELATED RANDOM COEFFICIENTS TRANSFORMATION MODEL

This study examines identification and estimation in a correlated random coefficients (CRC) model with an unknown transformation of the dependent variable, namely $\lambda \left (Y^{*}\right)=B_{0}+X^{\prime }B$ , where the latent outcome $Y^{*}$ may be subject to a certain kind of censoring mechanism, $\lambda (\cdot)$ is an unknown, one-to-one monotone function, and the random coefficients $\left (B_{0},B\right)$ are allowed to be correlated with one or several components of X. Under a conditional median independence plus a conditional median zero restriction, the mean of B is shown to be identified up to scale. Moreover, we show the derivative of the median structural function (MSF) is point identified. This derivative of MSF resembles the marginal treatment effect introduced by Heckman and Vytlacil (2005, Econometrica 73, 669–738). It generalizes the usual average treatment effect in a linear CRC model and coincides with $E(B)$ when $\lambda $ is equal to the identity function; it is invariant to both location and scale normalization on the coefficients. We develop estimators for the identified parameters and derive asymptotic properties for the derivative of MSF. An empirical example using the U.K. Family Expenditure Survey is provided.

A Baseline for Cross-Database 3D Human Pose Estimation

Vision-based 3D human pose estimation approaches are typically evaluated on datasets that are limited in diversity regarding many factors, e.g., subjects, poses, cameras, and lighting. However, for real-life applications, it would be desirable to create systems that work under arbitrary conditions (“in-the-wild”). To advance towards this goal, we investigated the commonly used datasets HumanEva-I, Human3.6M, and Panoptic Studio, discussed their biases (that is, their limitations in diversity), and illustrated them in cross-database experiments (for which we used a surrogate for roughly estimating in-the-wild performance). For this purpose, we first harmonized the differing skeleton joint definitions of the datasets, reducing the biases and systematic test errors in cross-database experiments. We further proposed a scale normalization method that significantly improved generalization across camera viewpoints, subjects, and datasets. In additional experiments, we investigated the effect of using more or less cameras, training with multiple datasets, applying a proposed anatomy-based pose validation step, and using OpenPose as the basis for the 3D pose estimation. The experimental results showed the usefulness of the joint harmonization, of the scale normalization, and of augmenting virtual cameras to significantly improve cross-database and in-database generalization. At the same time, the experiments showed that there were dataset biases that could not be compensated and call for new datasets covering more diversity. We discussed our results and promising directions for future work.

Bruxism: methods of application and results of treatment with botulinum neuroprotein (Relatox)

The article substantiates the need for the use of botulinum therapy in the management of bruxism as a movement disorder. We present the technique of injecting a new Russian botulinum neuroprotein Relatox into the masticatory muscles of patients with bruxism. We have the positive clinical effects of botulinum therapy, a decrease in the level of pain on the visual analogue scale, normalization of muscle activity according to the surface electromyography of masticatory muscles, a decrease in number of nocturnal bruxism according to abrasion on the foil surface on Brux Checker are shown.